NewAmsterdam Pharma Company NV XNAS: NAMS

NewAmsterdam Pharma Company NV Live Share Price Today, Share Analysis and Chart

Name: NewAmsterdam Pharma Company NV: Is Infosys Ltd. worth buying?
Item: NewAmsterdam Pharma Company NV
Rating: 0.945208375
Author: Trendlyne DVM scores

Weak Stock

Download real time

16.34 0.31 (1.93%)

40.12% Fall from 52W High

277.2K XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

Low Financial Strength

16.7 / 100

Expensive Valuation

9.3 / 100

Technically Bearish

33.0 / 100

Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

47

1Yr Price target upside is 188%

9 analysts

NewAmsterdam Pharma Compan... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

NewAmsterdam Pharma Company NV FAQ

How is NewAmsterdam Pharma Company NV today?

NewAmsterdam Pharma Company NV today is trading in the green, and is up by 1.93% at 16.34.

How has NewAmsterdam Pharma Company NV performed historically?

NewAmsterdam Pharma Company NV is currently trading up 1.93% on an intraday basis. In the past week the stock rose 9.66%. stock has been down -30.62% in the past quarter and fell -18.50% in the past year. You can view this in the overview section.